CEO Eyal Barad of Cannabics Pharmaceuticals Inc. (OTCQB: CNBX)

from Stock Day Media · host Stock Day Media

CEO Eyal Barad of Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), joins the show to discuss cancer therapy using cannabinoids, developing patient specific therapies, and the future of the medical cannabis industry. OTCQB: CNBX # cannabinoid based cancer therapy # Israel # cancer patients # tumors # Anorexia # fully licensed # Liquid Biopsy # personalized diagnostic tools # practitioners and patients # tailored therapies Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Nov 1, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

CEO Eyal Barad of Cannabics Pharmaceuticals Inc. (OTCQB: CNBX)

0:00 9:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 9 minutes long.

When was this Stock Day Media episode published?

This episode was published on November 1, 2018.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!